Home » Topics » Regulatory » Patents

Patents
RSS

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Takeda reports new carbapenems

April 1, 1997

New antitumor agents from Daiichi

April 1, 1997

Antimicrobial agents disclosed by Maruho

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Terumo describes antiallergic agents

April 1, 1997

Sanofi discloses agents for treating CRF-related disorders

March 27, 1997

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

New anxiolytics from American Home Products

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...